Joshua Barocas

Josh Barocas leads an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders and other vulnerable populations. His research, which uses clinical epidemiology, health economics, simulation modeling and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. He is engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for infections. His research is currently being funded by NIDA. He has also received NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI and the MGH Executive Committee on Research Fund for Medical Discovery. He currently serve as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. Barocas has published work and editorials in leading journals such as NEJM, Lancet Public Health, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases and Annals of Internal Medicine. His work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.